184 related articles for article (PubMed ID: 38763181)
1. Recent advances in the effect of adipose tissue inflammation on insulin resistance.
Yan K
Cell Signal; 2024 Aug; 120():111229. PubMed ID: 38763181
[TBL] [Abstract][Full Text] [Related]
2. Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance.
Kojta I; Chacińska M; Błachnio-Zabielska A
Nutrients; 2020 May; 12(5):. PubMed ID: 32375231
[TBL] [Abstract][Full Text] [Related]
3. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
Murakami T; Inagaki N; Kondoh H
Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
[TBL] [Abstract][Full Text] [Related]
4. Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications.
Longo M; Zatterale F; Naderi J; Parrillo L; Formisano P; Raciti GA; Beguinot F; Miele C
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31085992
[TBL] [Abstract][Full Text] [Related]
5. MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-γ.
Zhang M; Zhou Z; Wang J; Li S
Immunol Lett; 2016 Dec; 180():1-8. PubMed ID: 27746169
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction.
Khodabandehloo H; Gorgani-Firuzjaee S; Panahi G; Meshkani R
Transl Res; 2016 Jan; 167(1):228-56. PubMed ID: 26408801
[TBL] [Abstract][Full Text] [Related]
7. Rewiring of Lipid Metabolism in Adipose Tissue Macrophages in Obesity: Impact on Insulin Resistance and Type 2 Diabetes.
Dahik VD; Frisdal E; Le Goff W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752107
[TBL] [Abstract][Full Text] [Related]
8. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
Cusi K
Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes.
Russo L; Muir L; Geletka L; Delproposto J; Baker N; Flesher C; O'Rourke R; Lumeng CN
Mol Metab; 2020 Sep; 39():100983. PubMed ID: 32229247
[TBL] [Abstract][Full Text] [Related]
10. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes.
van Diepen JA; Robben JH; Hooiveld GJ; Carmone C; Alsady M; Boutens L; Bekkenkamp-Grovenstein M; Hijmans A; Engelke UFH; Wevers RA; Netea MG; Tack CJ; Stienstra R; Deen PMT
Diabetologia; 2017 Jul; 60(7):1304-1313. PubMed ID: 28382382
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance.
Lee BC; Lee J
Biochim Biophys Acta; 2014 Mar; 1842(3):446-62. PubMed ID: 23707515
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes.
Lee J
Arch Pharm Res; 2013 Feb; 36(2):208-22. PubMed ID: 23397293
[TBL] [Abstract][Full Text] [Related]
14. The role of uncoupling protein 2 in macrophages and its impact on obesity-induced adipose tissue inflammation and insulin resistance.
van Dierendonck XAMH; Sancerni T; Alves-Guerra MC; Stienstra R
J Biol Chem; 2020 Dec; 295(51):17535-17548. PubMed ID: 33453996
[TBL] [Abstract][Full Text] [Related]
15. Latent Inflammation and Defect in Adipocyte Renewal as a Mechanism of Obesity-Associated Insulin Resistance.
Vorotnikov AV; Stafeev IS; Menshikov MY; Shestakova MV; Parfyonova YV
Biochemistry (Mosc); 2019 Nov; 84(11):1329-1345. PubMed ID: 31760921
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance causes inflammation in adipose tissue.
Shimobayashi M; Albert V; Woelnerhanssen B; Frei IC; Weissenberger D; Meyer-Gerspach AC; Clement N; Moes S; Colombi M; Meier JA; Swierczynska MM; Jenö P; Beglinger C; Peterli R; Hall MN
J Clin Invest; 2018 Apr; 128(4):1538-1550. PubMed ID: 29528335
[TBL] [Abstract][Full Text] [Related]
17. IL-37 protects against obesity-induced inflammation and insulin resistance.
Ballak DB; van Diepen JA; Moschen AR; Jansen HJ; Hijmans A; Groenhof GJ; Leenders F; Bufler P; Boekschoten MV; Müller M; Kersten S; Li S; Kim S; Eini H; Lewis EC; Joosten LA; Tilg H; Netea MG; Tack CJ; Dinarello CA; Stienstra R
Nat Commun; 2014 Sep; 5():4711. PubMed ID: 25182023
[TBL] [Abstract][Full Text] [Related]
18. Enhanced lipid oxidation and maintenance of muscle insulin sensitivity despite glucose intolerance in a diet-induced obesity mouse model.
Trajcevski KE; O'Neill HM; Wang DC; Thomas MM; Al-Sajee D; Steinberg GR; Ceddia RB; Hawke TJ
PLoS One; 2013; 8(8):e71747. PubMed ID: 23951235
[TBL] [Abstract][Full Text] [Related]
19. Insulin action and resistance in obesity and type 2 diabetes.
Czech MP
Nat Med; 2017 Jul; 23(7):804-814. PubMed ID: 28697184
[TBL] [Abstract][Full Text] [Related]
20. Low proliferative potential of adipose-derived stromal cells associates with hypertrophy and inflammation in subcutaneous and omental adipose tissue of patients with type 2 diabetes mellitus.
Stafeev I; Podkuychenko N; Michurina S; Sklyanik I; Panevina A; Shestakova E; Yah'yaev K; Fedenko V; Ratner E; Vorotnikov A; Menshikov M; Yashkov Y; Parfyonova Y; Shestakova M
J Diabetes Complications; 2019 Feb; 33(2):148-159. PubMed ID: 30482492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
